Brief: Citigroup's Long Position In H-Shares Of Sinopharm Group Decreases To 4.86% - HKEX
Dec 24 (Reuters) - HKEX:
* CITIGROUP'S LONG POSITION IN H-SHARES OF SINOPHARM GROUP
DECREASES TO 4.86% ON DEC 18 FROM 5.38%
Further company coverage: 1099.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sinopharm
See all newsBrief: Sinopharm Group Says 9M Sinopharm Accord Net Income Attributable RMB952.5 Million (Oct 20)
Medical products distributor Sinopharm Group's prelim 9-month revenue slips
Brief: BlackRock's Long Position In H Shares Of Sinopharm Reduces To 9.23% On Oct 13, HKEX Shows
Sinopharm interim revenue edges down on softness in pharmaceutical distribution business
Brief: Sinopharm Group To Sell 30.13% Stake In China National Medicines Guorui Pharmaceutical For